GLANDPharmaceuticals
Gland Pharma Ltd — Balance Sheet
₹1696.10
+0.56%
Gland Pharma Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Work In Process | 436.62 Cr | 543.25 Cr | 461.46 Cr | 444.07 Cr | — |
| Raw Materials | 640.67 Cr | 559.92 Cr | 1.02K Cr | 505.03 Cr | — |
| Ordinary Shares Number | 16.48 Cr | 16.47 Cr | 16.47 Cr | 16.43 Cr | — |
| Share Issued | 16.48 Cr | 16.47 Cr | 16.47 Cr | 16.43 Cr | — |
| Total Debt | 313.73 Cr | 372.17 Cr | 4.45 Cr | 4.74 Cr | — |
| Tangible Book Value | 8.80K Cr | 8.37K Cr | 7.95K Cr | 7.15K Cr | — |
| Invested Capital | 9.42K Cr | 9.04K Cr | 7.96K Cr | 7.16K Cr | — |
| Working Capital | 5.22K Cr | 4.25K Cr | 6.17K Cr | 5.27K Cr | — |
| Net Tangible Assets | 8.80K Cr | 8.37K Cr | 7.95K Cr | 7.15K Cr | — |
| Capital Lease Obligations | 44.52 Cr | 52.38 Cr | 0.63 Cr | 0.81 Cr | — |
| Common Stock Equity | 9.15K Cr | 8.72K Cr | 7.96K Cr | 7.16K Cr | — |
| Total Capitalization | 9.23K Cr | 8.83K Cr | 7.96K Cr | 7.16K Cr | — |
| Total Equity Gross Minority Interest | 9.15K Cr | 8.72K Cr | 7.96K Cr | 7.16K Cr | — |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Stockholders Equity | 9.15K Cr | 8.72K Cr | 7.96K Cr | 7.16K Cr | — |
| Other Equity Interest | 0.05 Cr | 1.38 Cr | 1.67 Cr | 13.24 Cr | — |
| Retained Earnings | 7.16K Cr | 6.79K Cr | 6.02K Cr | 5.23K Cr | — |
| Additional Paid In Capital | 1.94K Cr | 1.93K Cr | 1.93K Cr | 1.90K Cr | — |
| Capital Stock | 16.48 Cr | 16.47 Cr | 16.47 Cr | 16.43 Cr | — |
| Common Stock | 16.48 Cr | 16.47 Cr | 16.47 Cr | 16.43 Cr | — |
| Total Liabilities Net Minority Interest | 2.07K Cr | 1.94K Cr | 818.81 Cr | 676.00 Cr | — |
| Total Non Current Liabilities Net Minority Interest | 509.33 Cr | 539.04 Cr | 89.68 Cr | 93.97 Cr | — |
| Other Non Current Liabilities | 41.38 Cr | 40.49 Cr | — | — | — |
| Non Current Pension And Other Postretirement Benefit Plans | 145.99 Cr | 137.21 Cr | 0.00 | — | — |
| Non Current Deferred Revenue | 41.38 Cr | 40.49 Cr | 0.00 | — | — |
| Non Current Deferred Taxes Liabilities | 214.81 Cr | 220.12 Cr | 84.20 Cr | 87.76 Cr | — |
| Long Term Debt And Capital Lease Obligation | 107.15 Cr | 141.22 Cr | 3.74 Cr | 4.48 Cr | — |
| Long Term Capital Lease Obligation | 29.49 Cr | 34.68 Cr | 0.48 Cr | 0.66 Cr | — |
| Long Term Debt | 77.66 Cr | 106.54 Cr | 3.26 Cr | 3.82 Cr | — |
| Long Term Provisions | 145.99 Cr | 137.21 Cr | 1.73 Cr | 1.73 Cr | — |
| Current Liabilities | 1.56K Cr | 1.40K Cr | 729.13 Cr | 582.02 Cr | — |
| Other Current Liabilities | 302.26 Cr | 0.39 Cr | 3.58 Cr | 4.06 Cr | — |
| Current Debt And Capital Lease Obligation | 206.58 Cr | 230.95 Cr | 0.71 Cr | 0.26 Cr | — |
| Current Capital Lease Obligation | 15.03 Cr | 17.70 Cr | 0.15 Cr | 0.15 Cr | — |
| Current Debt | 191.55 Cr | 213.24 Cr | 0.56 Cr | 0.11 Cr | — |
| Pensionand Other Post Retirement Benefit Plans Current | 154.80 Cr | 153.04 Cr | 31.32 Cr | 24.77 Cr | — |
| Current Provisions | 50.88 Cr | 58.91 Cr | 31.32 Cr | 24.77 Cr | — |
| Payables | 1.01K Cr | 928.61 Cr | 617.49 Cr | 519.02 Cr | — |
| Other Payable | 117.40 Cr | 109.22 Cr | 29.15 Cr | 38.19 Cr | — |
| Dividends Payable | 0.01 Cr | 0.00 | — | — | — |
| Total Tax Payable | 73.69 Cr | 51.64 Cr | 0.98 Cr | 17.98 Cr | — |
| Accounts Payable | 820.41 Cr | 767.75 Cr | 587.35 Cr | 462.85 Cr | — |
| Total Assets | 11.22K Cr | 10.66K Cr | 8.78K Cr | 7.83K Cr | — |
| Total Non Current Assets | 4.44K Cr | 5.02K Cr | 1.88K Cr | 1.98K Cr | — |
| Other Non Current Assets | 64.66 Cr | 97.62 Cr | 106.44 Cr | 83.61 Cr | — |
| Non Current Prepaid Assets | 61.02 Cr | 84.26 Cr | 43.48 Cr | 34.91 Cr | — |
| Non Current Deferred Taxes Assets | 52.07 Cr | 50.44 Cr | 0.00 | — | — |
| Investmentin Financial Assets | 0.00 | 654.50 Cr | 0.00 | 200.00 Cr | — |
| Goodwill And Other Intangible Assets | 353.90 Cr | 354.48 Cr | 11.66 Cr | 12.54 Cr | — |
| Other Intangible Assets | 105.70 Cr | 112.22 Cr | 11.66 Cr | 12.54 Cr | — |
| Goodwill | 248.20 Cr | 242.26 Cr | 0.00 | — | — |
| Net PPE | 3.97K Cr | 3.87K Cr | 1.80K Cr | 1.73K Cr | — |
| Accumulated Depreciation | -1.42K Cr | -1.04K Cr | -723.09 Cr | -578.68 Cr | — |
| Gross PPE | 5.40K Cr | 4.92K Cr | 2.52K Cr | 2.31K Cr | — |
| Construction In Progress | 181.66 Cr | 278.73 Cr | 240.18 Cr | 227.24 Cr | — |
| Other Properties | 358.58 Cr | 326.75 Cr | 205.75 Cr | 174.73 Cr | — |
| Machinery Furniture Equipment | 3.27K Cr | 2.78K Cr | 1.68K Cr | 1.52K Cr | — |
| Buildings And Improvements | 639.05 Cr | 594.32 Cr | 332.77 Cr | 320.29 Cr | — |
| Land And Improvements | 954.44 Cr | 931.68 Cr | 64.60 Cr | 63.85 Cr | — |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Current Assets | 6.78K Cr | 5.65K Cr | 6.90K Cr | 5.85K Cr | — |
| Other Current Assets | 531.36 Cr | 339.86 Cr | 247.78 Cr | 172.23 Cr | — |
| Restricted Cash | 0.01 Cr | 100.68 Cr | 7.84 Cr | 26.60 Cr | — |
| Prepaid Assets | 384.21 Cr | 238.13 Cr | 148.86 Cr | 125.34 Cr | — |
| Inventory | 1.69K Cr | 1.66K Cr | 1.95K Cr | 1.19K Cr | — |
| Other Inventories | 513.60 Cr | 465.44 Cr | 374.66 Cr | 177.42 Cr | — |
| Finished Goods | 94.33 Cr | 86.62 Cr | 88.67 Cr | 59.15 Cr | — |
| Other Receivables | 244.77 Cr | 153.66 Cr | 164.58 Cr | 217.95 Cr | — |
| Accounts Receivable | 1.52K Cr | 1.56K Cr | 871.39 Cr | 1.07K Cr | — |
| Allowance For Doubtful Accounts Receivable | -19.62 Cr | -19.16 Cr | -58.69 Cr | -5.21 Cr | — |
| Gross Accounts Receivable | 1.54K Cr | 1.58K Cr | 930.08 Cr | 1.08K Cr | — |
| Cash Cash Equivalents And Short Term Investments | 2.95K Cr | 1.94K Cr | 3.76K Cr | 3.22K Cr | — |
| Other Short Term Investments | 396.00 Cr | 1.58K Cr | 1.85K Cr | 2.93K Cr | — |
| Cash And Cash Equivalents | 2.56K Cr | 357.09 Cr | 1.91K Cr | 294.82 Cr | — |
| Available For Sale Securities | — | 654.50 Cr | — | 200.00 Cr | 6.95 Cr |
| Cash Financial | — | 357.09 Cr | 1.91K Cr | 249.82 Cr | 304.82 Cr |
| Cash Equivalents | — | — | 1.36K Cr | 45.00 Cr | 187.00 Cr |
| Taxes Receivable | — | — | — | — | 0.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Gland Pharma Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.